GRAPHEX GROUP LTD-SPON ADR (GRFX)

US38867H1041 - ADR

0.1999  +0 (+0.5%)

After market: 0.1949 -0.01 (-2.5%)

Fundamental Rating

1

GRFX gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 81 industry peers in the Professional Services industry. Both the profitability and financial health of GRFX have multiple concerns. GRFX does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

GRFX had negative earnings in the past year.
GRFX had a negative operating cash flow in the past year.
GRFX had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: GRFX reported negative operating cash flow in multiple years.

1.2 Ratios

With a Return On Assets value of -14.69%, GRFX is not doing good in the industry: 81.82% of the companies in the same industry are doing better.
GRFX has a Return On Equity of -37.45%. This is amonst the worse of the industry: GRFX underperforms 84.42% of its industry peers.
Industry RankSector Rank
ROA -14.69%
ROE -37.45%
ROIC N/A
ROA(3y)-8.67%
ROA(5y)-7.86%
ROE(3y)-25.35%
ROE(5y)-31.08%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of GRFX (32.92%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of GRFX has declined.
The Profit Margin and Operating Margin are not available for GRFX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.35%
GM growth 5Y-10.53%

1

2. Health

2.1 Basic Checks

GRFX does not have a ROIC to compare to the WACC, probably because it is not profitable.
GRFX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for GRFX has been increased compared to 5 years ago.
The debt/assets ratio for GRFX has been reduced compared to a year ago.

2.2 Solvency

GRFX has an Altman-Z score of -0.91. This is a bad value and indicates that GRFX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.91, GRFX is not doing good in the industry: 89.61% of the companies in the same industry are doing better.
GRFX has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.23, GRFX is in line with its industry, outperforming 57.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z -0.91
ROIC/WACCN/A
WACC4.37%

2.3 Liquidity

A Current Ratio of 0.73 indicates that GRFX may have some problems paying its short term obligations.
With a Current ratio value of 0.73, GRFX is not doing good in the industry: 89.61% of the companies in the same industry are doing better.
GRFX has a Quick Ratio of 0.73. This is a bad value and indicates that GRFX is not financially healthy enough and could expect problems in meeting its short term obligations.
GRFX has a worse Quick ratio (0.69) than 90.91% of its industry peers.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.69

1

3. Growth

3.1 Past

GRFX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -91.39%.
The Revenue for GRFX has decreased by -28.84% in the past year. This is quite bad
The Revenue has been growing by 8.15% on average over the past years. This is quite good.
EPS 1Y (TTM)-91.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.94%
Revenue 1Y (TTM)-28.84%
Revenue growth 3Y-9.11%
Revenue growth 5Y8.15%
Sales Q2Q%-38.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

GRFX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

GRFX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GRAPHEX GROUP LTD-SPON ADR

NYSEARCA:GRFX (11/22/2024, 8:04:01 PM)

After market: 0.1949 -0.01 (-2.5%)

0.1999

+0 (+0.5%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap9.87M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.69%
ROE -37.45%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 32.92%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.73
Quick Ratio 0.69
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-91.39%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-28.84%
Revenue growth 3Y-9.11%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y